Trial Profile
HEALEY ALS Platform Trial - Regimen D Pridopidine
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 17 Apr 2024
Price :
$35
*
At a glance
- Drugs Pridopidine (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms HEALEY ALS Platform
- 12 Apr 2024 According to a Prilenia Therapeutics media release, data from this study will be presented at the American Academy of Neurology (AAN) Annual Congress, in Denver, Colorado, April 13-18.
- 30 Jun 2023 New primary endpoint has been added -Mortality Event Rate (Baseline to 24 Weeks).
- 30 Jun 2023 Status changed from active, no longer recruiting to completed.